This Solicitation opportunity from Department Of Defense was posted on May 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
SODIUM CHLORIDE INJ
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract calls for the procurement of Sodium Chloride 0.9% Injection, USP, 500 mL, in quantities of 1 pack (24 units), under solicitation SPE2DP-26-T-3366, issued by the Department of Defense’s Medical Supply Chain Pharm FSA. Delivery is required within 20 days to destinations in Asheville, North Carolina, on a FOB destination basis with zero variance allowed in quantity. The item is regulated by the FDA and must comply with all applicable medical and safety standards, including marking per Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical acquisitions. Packaging must adhere to MIL-STD-2073-1E and supplemental instructions to ensure protection against damage and proper transportation via common carriers at the lowest cost. Each unit must be sealed and enclosed in commercial-grade shipping containers suitable for export when required. The product has a non-extendable shelf life of 24 months and must not contain any intentionally added mercury or mercury-containing compounds, except in specific exceptions such as batteries, fluorescent lights, or instrumentation as defined by NAVSEA, with all such items requiring shockproof design and secondary containment. Compliance with federal acquisition regulations is mandatory, including clauses related to safeguarding covered defense information, cyber incident reporting, and supply chain security, all governed by NIST SP 800-171. The contract mandates adherence to hazardous material labeling standards under OSHA’s Hazard Communication Standard, with exceptions only for items regulated under the FDCA or FIFRA. Offerors must hold a valid Unique Entity Identifier and CAGE code and declare their socioeconomic status, including small business, veteran-owned, or HUBZone eligibility, with full disclosures required for joint ventures or provision of covered defense telecommunications equipment. All submissions must be made electronically through DIBBS prior to the May 18, 2026 deadline, and payment will be processed via WAWF using approved document types such as invoice and receiving reports. The item is subject to inspection and acceptance at the delivery point, with full responsibility for compliance resting on the contractor, who must also flow down applicable clauses to subcontractors. The contract prohibits the use of parcel post and requires U.S.-flag vessels for overseas ocean shipments, while further requiring reporting of any cyber incidents within 72 hours and ensuring whistleblower protections are communicated to all employees.
General Info
Agency
NAICS
Place of Performance
100 MINUTEMAN DR, ASHEVILLE, NC, 28806-0000, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
SODIUM CHLORIDE 0.9% INJECTION, USP 500 ML,24'S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 PG = 24 EA
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
SPE2DP-26-T-3366
SECTION B
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
‘Regulation (xxx,xxxx), Class (I, II, or III). Even though a 510(K) (is/is not) required, it is necessary to meet other requirements for marketing. These include: Registration and Listing, Labeling, or GMP’s.’
CARDINAL HEALTH 200, LLC 07TA6 P/N 1567908 BAXTER HEALTHCARE CORP IV 04687 P/N 2B1323Q MCKESSON MEDICAL-SURGICAL GOVERNMENT 1EU19 P/N 54305 B. BRAUN MEDICAL INC 11171 P/N L8001 B. BRAUN MEDICAL INC 11171 P/N NDC00264-7800-10 BAXTER HEALTHCARE CORP IV 04687 P/N NDC00338-0049-03 ICU MEDICAL SALES, INC. 85RR5 P/N NDC00990-7983-03 TRIBALCO LLC 30TR5 P/N TICS.17.10277
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016724108 0001 PG 1.000
NSN/MATERIAL:6505013306268
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-330-6268 Quantity: 1 PG Purchase Request: 7016724108QTY: 1 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS